Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. [electronic resource]
Producer: 20001005Description: 493-503 p. digitalISSN:- 0003-4819
- AIDS-Related Opportunistic Infections -- prevention & control
- Adult
- Anti-Bacterial Agents -- adverse effects
- Anti-HIV Agents -- therapeutic use
- Azithromycin -- adverse effects
- CD4 Lymphocyte Count
- Disease Progression
- Double-Blind Method
- Female
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Immunocompromised Host
- Male
- Mycobacterium avium Complex
- Mycobacterium avium-intracellulare Infection -- prevention & control
- Placebos
- Proportional Hazards Models
- RNA, Viral -- blood
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.